Table IV Saponins Founded in Toothpaste Samples No. Sample-batch number Announced (mg/100 g) Founded (mg/100 g) (RSD/%) R1 Rg1 Re Rb1 Rd R1 Rg1 Re Rb1 Rd 1 Anti-allergic water moistens mint20230209 17.0 55 7.7 55 16.5 18.4(1.4) 56.9(0.9) 7.8(1.3) 56.0(3.9) 16.6(2.1) 2 Active peptide20230209 17.0 55 7.7 55 16.5 15.4(1.5) 54.1(1.4) 8.1(3.3) 53.4(1.8) 13.6(1.4) 3 Active peptide20230210 17.0 55 7.7 55 16.5 15.8(2.6) 55.2(2.6) 8.4(6.3) 54.3(2.5) 13.9(2.5) 4 Good teeth white20230303 10 30 4.2 30 9.0 10.5(2.3) 27(1.9) 3.4(2.8) 32.8(2.0) 9.4(1.3) 5 LAN20230210 7.5 25 3.5 25 7.5 6.5(3.1) 24.5(2.9) 3.4(2.4) 23.6(3.4) 8.4(3.5) 6 LAN20230211 7.5 25 3.5 25 7.5 6.5(4.1) 25.8(5.9) 3.4(5.1) 26.3(4.5) 5.9(4.6) 7 LAN20230212 7.5 25 3.5 25 7.5 7.5(0.2) 26.7(0.2) 3.8(0.6) 25.9(0.3) 7.0(0.3) 8 Fresh mint20230211 7.5 25 3.5 25 7.5 7.7(2.3) 26.6(0.4) 3.6(1.7) 26.4(0.8) 7.1(1.4) 9 Holly20230223 7.5 25 3.5 25 7.5 7.6(4.3) 26.8(4.4) 3.8(4.4) 26.1(4.5) 6.9(4.4) 10 Fresh mint20230213 7.5 25 3.5 25 7.5 7.4(2.9) 26.5(3.3) 3.9(6.0) 25.7(3.9) 6.9(3.4) 11 Fresh mint20230214 7.5 25 3.5 25 7.5 7.3(6.3) 25.9(6.5) 3.7(6.4) 25.3(6.0) 6.8(5.8) 12 Fresh water embellish20230216 7.5 25 3.5 25 7.5 7.7(0.7) 26.9(0.7) 3.9(1.2) 26.4(0.7) 7.3(0.8) 13 Pure and fresh morning dew20230218 7.5 25 3.5 25 7.5 7.2(2.8) 25.7(2.4) 3.8(2.5) 25.2(2.6) 6.7(2.7) 14 Pure and fresh morning dew20230209 7.5 25 3.5 25 7.5 7.5(2.9) 26.4(3.3) 3.9(6.0) 25.7(3.9) 6.9(3.4) 15 Yi chun white20230216 6.0 20 3.0 15 5.0 5.3(0.7) 18.3(1.6) 2.5(1.9) 13.7(0.9) 4.3(1.3) 16 Notoginseng bacteriostatic20221210 1.3 5 0.7 1 2.0 1.1(1.3) 4.9(3.6) 0.5(0.9) 0.8(2.6) 1.5(0.7) 17 Notoginseng toothpaste20221230 1.3 5 0.7 1 2.0 1.4(2.8) 5.4(3.9) 0.7(3.7) 1.1(1.5) 1.7(4.8) 517 SIMPLIFIED SALT-ASSISTED SOLVENT EXTRACTION

518 JOURNAL OF COSMETIC SCIENCE to the detection of saponins in other types of personal care products, which contributes to quality control throughout the efficacy personal care industry. ACKNOWLEDGMENT This study was supported by YUNNAN BAIYAO GROUP CO., LTD, Yunnan Province, China. There are no conflicts of interest for all authors. REFERENCES (1) Z. H. Y. Wu, Yunnan Flora (Science Press, Beijing, 2006), p. 509. (2) H. T. Pang, D. S. H. Luo, and J. Guo, Analysis of chemical constituents of Panax notoginseng and network pharmacological study on its anti-inflammatory mechanism, Chin. Tradit. Herb Drugs., 51, 139−148 (2020). (3) T. K. Yun, Y. S. Lee, H. Y. Kwon, and K. J. Choi, Saponin contents and anticarcinogenic effects of ginseng depending on types and ages in mice, Acta Pharmacol. Sin., 17, 293–298 (1996). (4) J. Hao, H. Hu, J. Liu, X. Wang, X. Liu, J. Wang, M. Niu, Y. Zhao, and X. Xiao, Integrated metabolomics and network pharmacology study on immunoregulation mechanisms of panax ginseng through macrophages, Evid. Based Complementary Altern. Med., 2019, 1–14 (2019). (5) X. Chen, Cardiovascular protection by ginsenosides and their nitric oxide releasing action, Clin. Exp. Pharmacol. Physiol., 23, 728–732 (2010). (6) T. Z. Tao, F. Chen, L. L. Bo, Q. Xie, W. J. Yi, Y. Zou, B. Hu, J. Li, and X. Deng, Ginsenoside Rg1 protects mouse liver against ischemia–reperfusion injury through anti-inflammatory and anti-apoptosis properties, J Surg Res., 191, 231–238 (2014). (7) M. M. Wang, M. Xue, Y. G. Xu, Y. Miao, N. Kou, L. Yang, Y. Zhang, and D. Z. Shi, Panax notoginseng saponin is superior to aspirin in inhibiting platelet adhesion to injured endothelial cells through COX pathway in vitro, Thromb. Res., 141, 146–152 (2016). (8) C. Yu, C. Diao, W. Xia, and B. Zhou, Determination of ginsenoside Rg1 in Shenfu injection by RP-HPLC, Chin. J. Pharm. Anal., 20, 263–265 (2000). (9) H. C. Wu, H. M. Liu, J. Bai, Y. Lu, and SH. Y. Du, Simultaneous determination of notoginsenoside R1, ginsenoside Rg1, ginsenoside Re and 20(S) protopanaxatriol in beagle dog plasma by ultra high performance liquid mass spectrometry after oral administration of a Panax notoginseng saponin preparation, J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 974, 42–47 (2015). (10) X. Y. Li, J. G. Sun, G. J. Wang, H. P. Hao, Y. Liang, Y. Zheng, B. Yan, and L. Sheng, Simultaneous determination of panax notoginsenoside R1, ginsenoside Rg1, Rd, Re and Rb1 in rat plasma by HPLC/ ESI/MS: platform for the pharmacokinetic evaluation of total panax notoginsenoside, a typical kind of multiple constituent traditional Chinese medicine, Biomed. Chromatogr., 21, 735–746 (2007). (11) Y. Tian, Y. Lu, J. Xie, Y. Cheng, R. Qi, Y. Wu, and S. Zhang, Rapid determination of ginsenoside Rg1, Re and Rb1 in ginseng samples by capillary electrophoresis, Anal. Methods., 1, 203 (2009). (12) Y. J. Kim, S. H. Han, J. Y. Jeon, M. H. Hwang, Y. J. Im, S. Y. Lee, S. W. Chae, and M. G. Kim, Validation of LC-MS/MS method for determination of ginsenoside Rg1 in human plasma, Anal. Sci. Tech., 26, 221–227 (2013). (13) M. S. Bispo, E. S. D. B. Morte, M. D. G. A. Korn, L. S. G. Teixeira, M. Korn, and A. C. S. Costa, Determination of Pb in river water samples by inductively coupled plasma optical emission spectrometry after ultrasound-assisted co-precipitation with manganese dioxide, Spectrochim. Acta B., 60, 653–658 (2005). (14) J. Zhou, J. Zhao, H. Yuan, Y. Meng, Y. Li, L. Wu, and X. Xue, Comparison of UPLC and HPLC for determination of trans-10-hydroxy-2-decenoic acid content in royal jelly by ultrasound-assisted extraction with internal standard, Chromatographia., 66, 185–190 (2007).